TECAN GROUP AG-REG (TEN.DE) Stock Fundamental Analysis
FRA:TEN - CH0012100191 - Common Stock
185.8 EUR
-1.7 (-0.91%)
We assign a fundamental rating of 4 out of 10 to TEN. TEN was compared to 18 industry peers in the Life Sciences Tools & Services industry. While TEN seems to be doing ok healthwise, there are quite some concerns on its profitability. TEN has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year TEN was profitable.
In the past year TEN had a positive cash flow from operations.
In the past 5 years TEN has always been profitable.
In the past 5 years TEN always reported a positive cash flow from operatings.
1.2 Ratios
TEN has a Return On Assets (3.26%) which is in line with its industry peers.
TEN has a worse Return On Equity (4.92%) than 66.67% of its industry peers.
TEN's Return On Invested Capital of 3.57% is on the low side compared to the rest of the industry. TEN is outperformed by 83.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.26% | ||
| ROE | 4.92% | ||
| ROIC | 3.57% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Profit Margin value of 6.96%, TEN perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
In the last couple of years the Profit Margin of TEN has declined.
The Operating Margin of TEN (8.02%) is worse than 77.78% of its industry peers.
In the last couple of years the Operating Margin of TEN has declined.
TEN has a Gross Margin (35.19%) which is in line with its industry peers.
TEN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.02% | ||
| PM (TTM) | 6.96% | ||
| GM | 35.19% |
OM growth 3Y-21.62%
OM growth 5Y-11.63%
PM growth 3Y-17.4%
PM growth 5Y-8.82%
GM growth 3Y-7.36%
GM growth 5Y-5.97%
2. Health
2.1 Basic Checks
TEN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
There is no outstanding debt for TEN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
TEN has an Altman-Z score of 3.92. This indicates that TEN is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.92, TEN is doing good in the industry, outperforming 77.78% of the companies in the same industry.
TEN has a debt to FCF ratio of 2.40. This is a good value and a sign of high solvency as TEN would need 2.40 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 2.40, TEN belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
TEN has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of TEN (0.05) is better than 94.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | 2.4 | ||
| Altman-Z | 3.92 |
ROIC/WACC0.67
WACC5.35%
2.3 Liquidity
A Current Ratio of 1.61 indicates that TEN should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.61, TEN is in line with its industry, outperforming 55.56% of the companies in the same industry.
TEN has a Quick Ratio of 1.18. This is a normal value and indicates that TEN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.18, TEN is in line with its industry, outperforming 50.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.61 | ||
| Quick Ratio | 1.18 |
3. Growth
3.1 Past
TEN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -37.09%.
The Earnings Per Share has been decreasing by -2.89% on average over the past years.
The Revenue has decreased by -9.34% in the past year.
Measured over the past years, TEN shows a small growth in Revenue. The Revenue has been growing by 7.97% on average per year.
EPS 1Y (TTM)-37.09%
EPS 3Y-18.77%
EPS 5Y-2.89%
EPS Q2Q%-19.43%
Revenue 1Y (TTM)-9.34%
Revenue growth 3Y-0.44%
Revenue growth 5Y7.97%
Sales Q2Q%-5.93%
3.2 Future
Based on estimates for the next years, TEN will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.55% on average per year.
The Revenue is expected to grow by 6.01% on average over the next years.
EPS Next Y-14.92%
EPS Next 2Y1.08%
EPS Next 3Y7.96%
EPS Next 5Y10.55%
Revenue Next Year-1.52%
Revenue Next 2Y1.32%
Revenue Next 3Y2.88%
Revenue Next 5Y6.01%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 35.12, which means the current valuation is very expensive for TEN.
Compared to the rest of the industry, the Price/Earnings ratio of TEN is on the same level as its industry peers.
TEN's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.03.
Based on the Price/Forward Earnings ratio of 24.47, the valuation of TEN can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of TEN is on the same level as its industry peers.
TEN's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.63.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.12 | ||
| Fwd PE | 24.47 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, TEN is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, TEN is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.69 | ||
| EV/EBITDA | 14.27 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.08%
EPS Next 3Y7.96%
5. Dividend
5.1 Amount
TEN has a Yearly Dividend Yield of 1.74%.
Compared to an average industry Dividend Yield of 0.70, TEN pays a better dividend. On top of this TEN pays more dividend than 100.00% of the companies listed in the same industry.
Compared to the average S&P500 Dividend Yield of 2.34, TEN is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.74% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
TEN pays out 60.24% of its income as dividend. This is not a sustainable payout ratio.
DP60.24%
EPS Next 2Y1.08%
EPS Next 3Y7.96%
FRA:TEN (8/25/2025, 7:00:00 PM)
185.8
-1.7 (-0.91%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners64.41%
Inst Owner ChangeN/A
Ins Owners0.26%
Ins Owner ChangeN/A
Market Cap2.38B
Analysts70.67
Price Target240.81 (29.61%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.74% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP60.24%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-13.14%
EPS NY rev (3m)-13.14%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.87%
Revenue NY rev (3m)-2.87%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.12 | ||
| Fwd PE | 24.47 | ||
| P/S | 2.47 | ||
| P/FCF | 16.69 | ||
| P/OCF | 13.55 | ||
| P/B | 1.74 | ||
| P/tB | 6.62 | ||
| EV/EBITDA | 14.27 |
EPS(TTM)5.29
EY2.85%
EPS(NY)7.59
Fwd EY4.09%
FCF(TTM)11.13
FCFY5.99%
OCF(TTM)13.71
OCFY7.38%
SpS75.31
BVpS106.48
TBVpS28.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.26% | ||
| ROE | 4.92% | ||
| ROCE | 5.08% | ||
| ROIC | 3.57% | ||
| ROICexc | 4.94% | ||
| ROICexgc | 55.8% | ||
| OM | 8.02% | ||
| PM (TTM) | 6.96% | ||
| GM | 35.19% | ||
| FCFM | 14.78% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-21.62%
OM growth 5Y-11.63%
PM growth 3Y-17.4%
PM growth 5Y-8.82%
GM growth 3Y-7.36%
GM growth 5Y-5.97%
F-Score6
Asset Turnover0.47
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | 2.4 | ||
| Debt/EBITDA | 0.43 | ||
| Cap/Depr | 44.19% | ||
| Cap/Sales | 3.42% | ||
| Interest Coverage | 29.79 | ||
| Cash Conversion | 115.44% | ||
| Profit Quality | 212.32% | ||
| Current Ratio | 1.61 | ||
| Quick Ratio | 1.18 | ||
| Altman-Z | 3.92 |
F-Score6
WACC5.35%
ROIC/WACC0.67
Cap/Depr(3y)48.59%
Cap/Depr(5y)64.5%
Cap/Sales(3y)3.23%
Cap/Sales(5y)3.91%
Profit Quality(3y)115.1%
Profit Quality(5y)122.68%
High Growth Momentum
Growth
EPS 1Y (TTM)-37.09%
EPS 3Y-18.77%
EPS 5Y-2.89%
EPS Q2Q%-19.43%
EPS Next Y-14.92%
EPS Next 2Y1.08%
EPS Next 3Y7.96%
EPS Next 5Y10.55%
Revenue 1Y (TTM)-9.34%
Revenue growth 3Y-0.44%
Revenue growth 5Y7.97%
Sales Q2Q%-5.93%
Revenue Next Year-1.52%
Revenue Next 2Y1.32%
Revenue Next 3Y2.88%
Revenue Next 5Y6.01%
EBIT growth 1Y-26.42%
EBIT growth 3Y-21.96%
EBIT growth 5Y-4.59%
EBIT Next Year73.39%
EBIT Next 3Y30.72%
EBIT Next 5Y19.04%
FCF growth 1Y32.18%
FCF growth 3Y-3.25%
FCF growth 5Y9.5%
OCF growth 1Y17.54%
OCF growth 3Y-4.37%
OCF growth 5Y8.5%